Pharmacological aspects

Guldberg HC, Marsden CA (1975) Catechol-O-methyl transferase Pharmacological aspects and physiological role. Pharmacol Rev 27 135-206... 

Michel PP, Lambeng N, Ruberg M (1999) Neuro-pharmacologic aspects of apoptosis significance for neurodegenerative diseases. Clin Neuropharmacol 22 137-150... 

Kanai Y, Hediger MA (2004) The glutamate/neutral amino acid transporter family SLC1 molecular, physiological and pharmacological aspects. Pfliigers Arch 447 469-479... 

FIGURE 1-3. Drug-receptor interactions. (Adapted from Reiss B/ans, Pharmacological Aspects of Nursing C re, 3rd ed.)... 

Each volume will be thematic, dealing with a specific and related subject that will cover fundamental, basic aspects including synthesis, isolation, purification, physical and chemical properties, stability and reactivity, reactions involving mechanisms, intra- and intermolecular transformations, intra- and intermolecular rearrangements, applications as medicinal agents, biological and biomedical studies, pharmacological aspects, applications in material science, and industrial and structural applications. 

Kalix P, Braenden O Pharmacological aspects of the chewing of khat leaves. Pharmacol Rev 37 149-164, 1985... 

Perbellini L, Olivato D, Zedde A, et al. 1991. Acute trichloroethylene poisoning by ingestion clinical and pharmacological aspects. Intensive Care Med 17 234-235. 

Fareed J., Callas D. D. Pharmacological aspects of thrombin inhibitors A developmental perspective. Vessels 1995 1,15-24. 

Nishino, S. Mignot, E. (1997). Pharmacological aspects of human and canine narcolepsy. Prog. Neurobiol. 52, 27-78. 

Glennon RA (1996). Classic hallucinogens. In CR Schuster and MJ Kuhar (eds), Pharmacological Aspects of Drug Dependence Towards an Integrated Neurobehavioral Approach. Springer-Verlag, Berlin. 

C. A., Ramachandra, M., Pastan, I., Gottesman, M. M., Biochemical, cellular, and pharmacological aspects of the multidrug transporter, Annu. 

Kuhlmann J. Alternative strategies in drug development clinical pharmacological aspects. Int J Clin Pharmacol Ther 1999 37[12] 575—583. 

Leurs, R., Smit, M. J. and Timmerman, H. Molecular pharmacological aspects of histamine receptors. Pharmacol. Ther. 66 413-463,1995. 

Way, J.L. 1981. Pharmacologic aspects of cyanide and its antagonism. Pages 29-40 in B. Vennesland, E.E. Conn, C.J. Knowles, J. Westley, and F. Wissing (eds.). Cyanide in Biology. Academic Press, New York. 

More recently the concept of ADMET profile (Absorption Distribution Metabolism Excretion Toxicity profile) has further streamlined the molecular pharmacology aspects of these drugs with the ultimate objective of providing efficient target directed drugs with least toxicity. 

Leurs R, Smit MJ. Timmerman H Molecular and pharmacological aspects of histamine receptors. Pharmacol Ther 1995 66 413-463. 

Bio-Organic Heterocycles Synthetic, Physical, Organic and Pharmacological Aspects edited by H.C. van der Plas, L. Otvds and M. Slmon3d... 

The greater part of the researches dealing with physiological and pharmacological aspects of biguanides have been cited in Section IX dealing with their medical uses this discussion was therefore concerned mostly... 

Jarukamjom K, Nemoto N. (2008) Pharmacological aspects of Andrographis paniculata on health and its major diterpenoid constituent andrographolide. J Health Sci 54 370-381. 

Brahmachri Q Mondal S, Gangopadhyay A, Gorai D, Mukhopadhyay B, Saha S, Brahmachari AK. (2004) Swertia (Gentianaceae) Chemical and pharmacological aspects. Chem Biodivers 1 1627-1651. 

Beck has contributed an incisive review of investigations from his laboratory and those of other scientists on the cellular pharmacological aspects of resistance to vinblastine and related compounds (76). Important cellular characteristics that are frequently associated with resistance to vinblastine include cross-resistance, not only to closely related compounds such as vincristine and vindesine but also to other basic naturally occurring compounds. Concomitant resistance to vinblastine and representative anthracyclines (e.g., doxorubicin) may involve reduced abilities... 

Brooks AM and Gillies WE. Ocular beta blockers in glaucoma management Clinical pharmacology aspects. Drugs Aging 1992 2 208-221. 

---